KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $21.39 $29.07 Friday, 26th Apr 2024 ARWR stock ended at $22.12. This is 1.14% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.95% from a day low at $21.72 to a day high of $22.36.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Apr 27, 2023 $36.00 $36.02 $34.91 $34.96 1 090 868
Apr 26, 2023 $34.47 $35.78 $33.11 $35.52 1 587 014
Apr 25, 2023 $35.02 $36.00 $33.44 $33.58 3 609 240
Apr 24, 2023 $30.70 $31.19 $29.84 $30.02 618 812
Apr 21, 2023 $30.17 $30.90 $30.05 $30.87 708 036
Apr 20, 2023 $30.00 $30.35 $29.66 $29.92 654 899
Apr 19, 2023 $30.38 $30.88 $30.20 $30.46 532 011
Apr 18, 2023 $31.64 $31.64 $30.10 $30.40 680 109
Apr 17, 2023 $30.87 $31.85 $30.65 $31.34 1 051 631
Apr 14, 2023 $30.47 $31.42 $29.97 $30.46 966 092
Apr 13, 2023 $28.78 $31.41 $28.78 $30.50 1 385 883
Apr 12, 2023 $27.81 $29.74 $27.43 $28.56 2 182 510
Apr 11, 2023 $25.69 $26.37 $25.69 $26.23 720 007
Apr 10, 2023 $26.00 $26.00 $25.23 $25.51 671 204
Apr 06, 2023 $25.33 $26.48 $24.92 $26.17 758 223
Apr 05, 2023 $25.09 $25.54 $24.77 $25.27 720 953
Apr 04, 2023 $25.73 $25.75 $24.64 $25.16 826 291
Apr 03, 2023 $25.38 $25.86 $25.12 $25.56 856 584
Mar 31, 2023 $24.59 $25.56 $24.43 $25.40 1 092 347
Mar 30, 2023 $24.88 $24.94 $24.05 $24.43 697 205
Mar 29, 2023 $24.52 $24.78 $24.14 $24.74 754 395
Mar 28, 2023 $24.25 $24.59 $24.12 $24.26 697 881
Mar 27, 2023 $24.34 $24.81 $24.09 $24.43 1 046 822
Mar 24, 2023 $23.95 $24.33 $23.09 $24.29 846 710
Mar 23, 2023 $23.97 $24.40 $23.50 $23.68 958 688
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT